IRIS UniCatt

Mercuri, Eugenio Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.084
EU - Europa 16.038
AS - Asia 15.866
SA - Sud America 3.218
AF - Africa 435
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 15
Totale 53.710
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.479
SG - Singapore 7.520
DE - Germania 4.524
CN - Cina 3.442
IT - Italia 3.110
BR - Brasile 2.623
SE - Svezia 1.776
VN - Vietnam 1.486
FR - Francia 1.432
NL - Olanda 938
GB - Regno Unito 766
IE - Irlanda 726
UA - Ucraina 702
IN - India 580
ID - Indonesia 496
JP - Giappone 482
FI - Finlandia 467
RU - Federazione Russa 420
HK - Hong Kong 355
PL - Polonia 332
CA - Canada 292
BD - Bangladesh 243
AR - Argentina 237
TR - Turchia 226
MX - Messico 182
IQ - Iraq 174
KR - Corea 172
ES - Italia 152
ZA - Sudafrica 136
AT - Austria 123
BE - Belgio 100
EC - Ecuador 91
PK - Pakistan 89
SA - Arabia Saudita 86
CZ - Repubblica Ceca 85
IR - Iran 71
CO - Colombia 64
CH - Svizzera 63
LT - Lituania 59
MA - Marocco 55
VE - Venezuela 53
PH - Filippine 49
UZ - Uzbekistan 45
EG - Egitto 44
AE - Emirati Arabi Uniti 43
IL - Israele 42
AU - Australia 41
CL - Cile 41
KE - Kenya 39
PY - Paraguay 37
CI - Costa d'Avorio 36
PE - Perù 34
JO - Giordania 33
RO - Romania 31
TN - Tunisia 31
PA - Panama 29
RS - Serbia 25
KZ - Kazakistan 23
BG - Bulgaria 22
DZ - Algeria 21
MY - Malesia 21
NP - Nepal 21
OM - Oman 20
UY - Uruguay 20
GR - Grecia 19
PT - Portogallo 19
AZ - Azerbaigian 17
JM - Giamaica 17
DK - Danimarca 16
HN - Honduras 16
AL - Albania 15
CR - Costa Rica 15
NO - Norvegia 15
TH - Thailandia 15
TW - Taiwan 14
DO - Repubblica Dominicana 13
HR - Croazia 13
HU - Ungheria 13
MK - Macedonia 13
NG - Nigeria 13
SK - Slovacchia (Repubblica Slovacca) 13
BY - Bielorussia 12
KG - Kirghizistan 12
LB - Libano 12
TT - Trinidad e Tobago 12
BH - Bahrain 11
BO - Bolivia 11
PS - Palestinian Territory 11
AM - Armenia 10
ET - Etiopia 10
NZ - Nuova Zelanda 9
LK - Sri Lanka 8
MD - Moldavia 8
SN - Senegal 8
A2 - ???statistics.table.value.countryCode.A2??? 7
LV - Lettonia 7
SY - Repubblica araba siriana 7
AO - Angola 6
GE - Georgia 6
NI - Nicaragua 6
Totale 53.586
Salva come PNG Salva come JPEG
Città #
Singapore 4.196
San Jose 2.085
Chandler 2.042
Ashburn 2.032
Amsterdam 736
New York 731
Dublin 678
Beijing 623
Frankfurt am Main 615
Rome 569
Los Angeles 546
Ho Chi Minh City 521
Hefei 505
Jakarta 448
Tokyo 438
Munich 433
Lauterbourg 432
Jacksonville 413
Milan 383
San Mateo 375
Hanoi 363
Hong Kong 322
Boston 273
Nanjing 266
Warsaw 265
São Paulo 263
Dallas 260
Wilmington 258
Moscow 235
Marseille 218
Houston 216
Chicago 199
Helsinki 198
Ann Arbor 192
Dearborn 187
Nürnberg 177
The Dalles 164
Seoul 161
Buffalo 160
Woodbridge 159
Princeton 156
Santa Clara 150
Seattle 147
Kent 138
Fairfield 136
Lawrence 128
Council Bluffs 126
London 116
Redwood City 114
Orem 111
Nuremberg 110
Bremen 103
Cattolica 103
Montreal 99
Brooklyn 98
Denver 98
Nanchang 98
Paris 97
Atlanta 93
Chennai 93
Stockholm 90
Johannesburg 89
Brussels 82
Toronto 82
Boardman 80
Shanghai 77
Poplar 76
Redmond 76
Da Nang 74
Baghdad 73
Lancaster 70
Rio de Janeiro 67
Mexico City 66
Hebei 65
Phoenix 65
Norwalk 63
Düsseldorf 62
Turku 61
Pune 59
San Francisco 58
Izmir 56
Augusta 54
Haiphong 54
Hangzhou 54
Belo Horizonte 53
Detroit 53
Guangzhou 52
Dhaka 51
Brno 50
Mountain View 50
Shenyang 50
Ankara 49
Lappeenranta 49
Vienna 48
Brasília 47
Palermo 47
Tianjin 47
Changsha 45
Jiaxing 45
Jeddah 42
Totale 28.082
Salva come PNG Salva come JPEG
Nome #
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 949
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 643
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 499
Tele-riabilitazione con il Training Lettura Ritmica: Applicazione a distanza di un training ritmico-musicale per il potenziamento della lettura nella dislessia evolutiva 388
Validation and cross-cultural adaptation of the Italian version of the Pediatric Eating Assessment Tool (I-PEDI-EAT-10) in genetic syndromes 375
Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module 322
Hammersmith Infant Neurological Examination in infants born at term: Predicting outcomes other than cerebral palsy 314
The visual function assessment: from birth to the follow up 313
Reliability of the Performance of Upper Limb assessment in Duchenne muscular dystrophy 309
Cortical visual function in preterm infants in the first year. 275
Neurological examination of preterm infants a term equivalent age 269
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 266
Hospital admissions from the emergency department of adult patients affected by myopathies 257
Spinal muscular atrophy 246
Use of the Hammersmith Infant Neurological Examination in Infants With Cerebral Palsy: A Critical Review of the Literature 240
Performance of Upper Limb module for Duchenne muscular dystrophy 234
Enhanced human brain associative plasticity in Costello syndrome 228
Prognostic value of EEG performed at term age in preterm infants. 227
Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia 221
Specific Learning Disorders (SLD) and behavior impairment: Comorbidity or specific profile? 217
Application of a neonatal assessment of visual function in a population of low risk full-term newborn. 216
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 215
Sleep-potentiated epileptiform activity in early thalamic injuries: Study in a large series (60 cases) 207
Assessing floppy infants: a new module 204
-Thalamic atrophy in infants with PVL and cerebral visual impairment 201
Crossed cerebellar atrophy of prenatal onset 201
Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome 195
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients 190
Neurological assessment of newborns with spinal muscular atrophy identified through neonatal screening 187
Developmental milestones in type I spinal muscular atrophy 186
External hydrocephalus in discordant birth weight twins: a case report 182
Development of clinical signs in low risk term born infants with neonatal hyperexcitability 182
Longitudinal assessment of perceptual-motor abilities in pre-school preterm children 182
A current approach to heart failure in Duchenne muscular dystrophy 182
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 181
Co-occurrence of fragile x syndrome with a second genetic condition: Three independent cases of double diagnosis 181
SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCR. 179
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design. 178
Visual development in prenatal post-haemorragic ventricular dilatation 178
Early visual assessment in preterm infants with and without brain lesions: correlation with visual and neurodevelopmental outcome at 12 months. 176
Use of the Hammersmith Infant Neurological Examination in infants with cerebral palsy: a critical review of the literature. 175
DMD myogenic cells from urine-derived stem cells recapitulate the dystrophin genotype and phenotype 175
Broad phenotypic spectrum and genotype-phenotype correlations in GMPPB-related dystroglycanopathies: an Italian cross-sectional study. 175
Predictive models in SMA II natural history trajectories using machine learning: A proof of concept study 175
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis 174
Early assessment of visual function in preterm infants: how early is early? 172
Early visual and neuro-development in preterm infants with and without retinopathy 172
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey 171
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy 169
Early development in Dravet syndrome; visual function impairment precedes cognitive decline 169
Sleep disturbances in preschool age children with cerebral palsy: a questionnaire study 167
Neuropsychological development in children with Dravet syndrome. 165
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study 165
Type I SMA “new natural history”: long-term data in nusinersen-treated patients 165
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 164
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standards of Care? 164
Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in naïve patients with spinal muscular atrophy and following switch from other therapies 163
Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy 163
Antenatal post-hemorragic ventriculomegaly: a prospective follow-up study 163
Intragenic KANSL1 mutations and chromosome 17q21.31 deletions: broadening the clinical spectrum and genotype-phenotype correlations in a large cohort of patients 163
Assessing Joint Hypermobility in Preschool-Aged Children 163
Muscle MRI in Becker muscular dystrophy 162
Body mass index in type 2 spinal muscular atrophy: a longitudinal study 160
Muscle MRI in Becker muscular dystrophy 160
Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype 159
Perceptual-motor abilities in pre-school preterm children 159
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 159
SMA-miRs (MiR-181a- 5p, -324-5p, and -451a) are overexpressed in spinal muscular atrophy skeletal muscle and serum samples 159
Long Term Memory Profile of Disorders Associated with Dysregulation of the RAS-MAPK Signaling Cascade. 158
Longitudinal Cognitive Assessment in Low-Risk Very Preterm Infants 157
Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome? 156
Sleep disorders in autism spectrum disorder pre-school children: An evaluation using the sleep disturbance scale for children 156
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 155
Cardiac Function in Types II and III Spinal Muscular Atrophy: Should We Change Standars of Care? 155
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 154
Muscle MRI: Out of the tunnel. 154
Neuropsychological development in children with Dravet syndrome 153
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol 153
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 153
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 152
Nusinersen in type 1 spinal muscular atrophy: Twelve-month real-world data 151
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 151
Hammersmith Infant Neurological Examination in low-risk infants born very preterm: a longitudinal prospective study 151
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial 150
A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy 150
Contactless: a new personalised telehealth model in chronic pediatric diseases and disability during the COVID-19 era 150
Visual processing in Noonan syndrome: dorsal and ventral stream sensitivity 149
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy 149
Age related treatment effect in type II Spinal Muscular Atrophy pediatric patients treated with nusinersen 149
Predominant distal muscle involvement in spinal muscular atrophy 148
Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy 148
Joint Laxity in Preschool Children Born Preterm 147
Co-occurrence of fragile x syndrome with a second genetic condition: Three independent cases of double diagnosis 147
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: Towards specific guidelines and standard operating procedures for the molecular diagnosis 146
Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine 146
FGF17, a gene involved in cerebellar development, is downregulated in a patient with Dandy-Walker malformation carrying a de novo 8p deletion 146
Revised upper limb module for spinal muscular atrophy: Development of a new module 146
Respiratory function and therapeutic expectations in DMD: Families experience and perspective 146
Can the CHOP-INTEND be used as An Outcome Measure in the First Months of Age? Implications for Clinical Trials and Real World Data 145
Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy 145
Totale 20.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 219.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 219.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021287 0 0 0 0 0 0 0 0 0 0 266 21
2021/20222.612 222 137 75 185 141 104 52 418 144 178 471 485
2022/20236.233 714 766 454 927 398 780 377 543 759 89 255 171
2023/20244.514 185 919 143 293 171 711 474 202 108 229 449 630
2024/20259.194 211 238 670 445 775 442 427 419 1.293 772 1.897 1.605
2025/202624.167 3.252 800 1.654 3.072 4.334 2.861 4.006 1.138 1.370 1.555 125 0
Totale 54.400